Arvinas (ARVN) FCF Margin (2017 - 2026)

Arvinas' (ARVN) quarterly FCF Margin came in at 451.92% in Q1 2026, down 40462.0% year-on-year from N/an in Q1 2025, and down 48.04% quarter-over-quarter from 305.26% in Q4 2025.

Arvinas (ARVN) FCF Margin (2017 - 2026) Analysis & Trends

Arvinas' FCF Margin history runs 10 years deep, the most recent figure standing at 451.92% for Q1 2026.

  • On a quarterly basis, FCF Margin fell 40462.0% year-over-year to 451.92% in Q1 2026; TTM through Mar 2026 was 285.57%, a 22633.0% decrease from a year earlier, with the FY2025 full-year figure at 104.38%, down 525.0% from the prior year.
  • FCF Margin eased to 451.92% in Q1 2026 per ARVN's latest filing, from 305.26% in the prior quarter.
  • Across five years, FCF Margin topped out at 193.04% in Q4 2023 and bottomed at 451.92% in Q1 2026.
  • The 5-year median for FCF Margin is 200.0% (2022), against an average of 194.59%.
  • Biggest YoY gain for FCF Margin was 64310 bps in 2022; the steepest drop was 754301 bps in 2022.
  • Year by year, FCF Margin stood at 187.83% in 2022, then jumped by 203 bps to 193.04% in 2023, then sank by 174 bps to 142.57% in 2024, then sank by 114 bps to 305.26% in 2025, then plunged by 48 bps to 451.92% in 2026.
  • Per Business Quant, the three latest ARVN FCF Margin figures stand at 451.92% (Q1 2026), 305.26% (Q4 2025), and 141.29% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 10.45%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 43.35%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.53%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Arvinas 519.68 Mn -95.22 Mn - -451.92%

Historic Data

Download Data
DateValue
Mar 31, 2026 -451.92%
Dec 31, 2025 -305.26%
Sep 30, 2025 -141.29%
Jun 30, 2025 -431.25%
Mar 31, 2025 -47.30%
Dec 31, 2024 -142.57%
Sep 30, 2024 -125.68%
Jun 30, 2024 64.71%
Mar 31, 2024 -385.38%
Dec 31, 2023 193.04%
Sep 30, 2023 -248.27%
Jun 30, 2023 -163.85%
Mar 31, 2023 -284.00%
Dec 31, 2022 -187.83%
Sep 30, 2022 -200.00%
Jun 30, 2022 -227.81%
Mar 31, 2022 -223.40%
Dec 31, 2021 -108.73%
Sep 30, 2021 7,343.01%
Jun 30, 2021 -870.91%